Dintenfass David
SEC CIK 2010288 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HUM | Humana | Pres, Enterprise Growth | 25.4K | — | — | 9 | 2024-02-21 | 2026-05-01 |
Most active insiders at HUM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Shetty Sanjay K | Pres, CenterWell | $150.0K | — |
| 2 | Nundy Shantanu | Chief Medical Off | — | — |
| 3 | Field Robert Stuart | Dir | — | — |
| 4 | Martin Aaron | Pres, Medicare Advantage | — | — |
| 5 | Mehta Japan | CIO | — | — |
| 6 | Dintenfass David | Pres, Enterprise Growth | — | — |
| 7 | Rechtin James A. | Pres, CEO | — | — |
| 8 | Renaudin George II | Pres, Insurance | — | — |
| 9 | Felter John-Paul W. | SVP, Chief Accting Off, Cont | — | — |
| 10 | Smith Paul John | Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 15:54 | 2026-05-01 | HUM | Humana | Dintenfass David | Pres, Enterprise Growth | A - Grant | $0.00 | +11.3K | 25.4K | +80% | $0 | |
| 2026-02-24 | 2026-02-21 | HUM | Humana | Dintenfass David | Pres, Enterprise Growth | M - OptEx | $0.00 | +3,858 | 15.3K | +34% | $0 | |
| 2026-02-24 | 2026-02-21 | HUM | Humana | Dintenfass David | Pres, Enterprise Growth | F - Tax | $189.66 | -1,182 | 14.1K | -8% | -$224.2K | |
| 2025-12-17 | 2025-12-15 | HUM | Humana | Dintenfass David | Pres, Enterprise Growth | F - Tax | $270.16 | -918 | 15.3K | -6% | -$248.0K | |
| 2025-12-17 | 2025-12-15 | HUM | Humana | Dintenfass David | Pres, Enterprise Growth | M - OptEx | $0.00 | +2,032 | 16.2K | +14% | $0 | |
| 2025-02-25 | 2025-02-21 | HUM | Humana | Dintenfass David | Pres, Enterprise Growth | F - Tax | $258.58 | -1,175 | 11.9K | -9% | -$303.8K | |
| 2025-02-25 | 2025-02-24 | HUM | Humana | Dintenfass David | Pres, Enterprise Growth | A - Grant | $0.00 | +4,360 | 16.2K | +37% | $0 | |
| 2024-12-17 | 2024-12-15 | HUM | Humana | Dintenfass David | Pres, Enterprise Growth | F - Tax | $271.68 | -261 | 13.0K | -2% | -$70.9K | |
| D | 2024-02-23 | 2024-02-21 | HUM | Humana | Dintenfass David | Pres, Enterprise Growth | A - Grant | $0.00 | +13.3K | 13.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations